Legendary Football Player Pele Is No Longer Responding To The Chemotherapy In His Fight Against Bowel Cancer !

- Advertisement -

Pele : According to reports, Pele has been transferred to a hospital’s palliative care unit because his cancer is no longer responding to chemotherapy.

According to Brazilian publication Folha, football star Pele has “shifted into palliative care” and is “no longer responding to chemotherapy.”

Pele was readmitted to the Albert Einstein Hospital in Sao Paulo on Tuesday, where the most recent official medical bulletin stated that his status was stable

- Advertisement -

According to Folha, the 82-year-old is no longer responding to the chemotherapy he has been receiving for colon cancer since last September, and because he is receiving end-of-life care, he won’t be having any more intrusive procedures.

Fans raised a banner in favour of the former striker before Brazil’s World Cup match against Cameroon on Friday.

Pele also made a thank-you post on Instagram for the “get well soon” message that was projected onto a structure in Qatar, the country hosting the World Cup. In the post, he thanked everyone for their “good vibes” and explained that he was just making his “monthly visit to the hospital.”

- Advertisement -

Additionally, according to the publication, he was admitted to the hospital earlier this week with cardiac difficulties and a general edoema, as previously reported by ESPN Brasil.

In an Instagram post on Thursday, Pele explained that he was visiting the hospital on a “weekly basis” and thanked his followers for their kind words.

- Advertisement -

The former striker for Brazil, Santos, and New York Cosmos uploaded a photo of his face projected on a building in Qatar, the country hosting the World Cup, along with the phrase “Get better soon.”Prior to their country’s 1-0 loss against Cameroon on Friday, Brazilian supporters at the Lusail Stadium displayed a sign with the same message.

- Advertisement -

Related articles



Please enter your comment!
Please enter your name here

Share article


Latest articles


Subscribe to stay updated.